Quality of life of patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C. Results from the EORTC phase-III trial 30893.

2001 ◽  
Vol 11 (1) ◽  
pp. 104-105
Author(s):  
Andrea Tubaro
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
Mitomycin C ◽  
Poor Prognosis ◽  
Phase Iii ◽  
Newly Diagnosed ◽  
Phase Iii Trial

Quality of Life of Patients with Newly Diagnosed Poor Prognosis M1 Prostate Cancer Undergoing Orchiectomy without or with Mitomycin C

2000 ◽  
Vol 37 (5) ◽  
pp. 541-551 ◽  
Author(s):  
S.D. Fosså ◽  
D. Curran ◽  
N.K. Aaronson ◽  
F. Keuppens ◽  
J. Kliment ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
Mitomycin C ◽  
Poor Prognosis ◽  
Newly Diagnosed

A phase III trial of docetaxel–estramustine in high-risk localised prostate cancer: A planned analysis of response, toxicity and quality of life in the GETUG 12 trial

2012 ◽  
Vol 48 (2) ◽  
pp. 209-217 ◽  
Author(s):  
Karim Fizazi ◽  
Francois Lesaunier ◽  
Remy Delva ◽  
Gwenaëlle Gravis ◽  
Frederic Rolland ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
High Risk ◽  
Phase Iii ◽  
Phase Iii Trial
Sign in / Sign up

Export Citation Format

Share Document